< Back to companies
Brainify.AI

Brainify.AI

Albany, New York, United States

Brainify.AI is an AI biomarker platform for the development of novel treatments for depression that increases the likelihood of new treatment approval and increases drug efficacy. We are members of J&J Labs and Merck DSS. Brainify.AI is backed by Merck GHI Fund, Northpond, and Kodori VC

Only accessible to MedStartr community members. Join now

Company Info

Founded
2021
Website
brainify.ai/

Categories

DepressionBiomarker MonitoringDrug DevelopmentAI / ML

Disease Areas

Technologies

AI/Machine LearningBiomarkersDrug DevelopmentPlatform
Only accessible to MedStartr community members. Join now

What do you think of Brainify.AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now